COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier-Reference-Cited by-同舟云学术

COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier

Published:2022-02 Issue:2 Volume:10 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Enomoto Takatoshi¹^ORCID,Shiroyama Takayuki¹^ORCID,Hirata Haruhiko¹,Amiya Saori¹,Adachi Yuichi¹,Niitsu Takayuki¹,Noda Yoshimi¹,Hara Reina¹,Fukushima Kiyoharu¹,Suga Yasuhiko¹,Miyake Kotaro¹,Koyama Shohei¹,Iwahori Kota¹,Nagatomo Izumi¹,Tokuhira Natsuko²,Uchiyama Akinori²,Takeda Yoshito¹,Kumanogoh Atsushi¹³⁴⁵

Affiliation:

1. Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan

2. Department of Anesthesiology and Intensive Care Medicine Osaka University Graduate School of Medicine Osaka Japan

3. Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC) Osaka University Osaka Japan

4. Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI) Osaka University Osaka Japan

5. Center for Infectious Disease for Education and Research (CiDER) Osaka University Osaka Japan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.5463

Reference13 articles.

1. Analysis of Epidemiological and Clinical Features in Older Patients With Coronavirus Disease 2019 (COVID-19) Outside Wuhan

2. Human T leukaemia Type 1 and COVID-19

3. False positive antibody results against human T-cell lymphotropic virus in patients with severe acute respiratory syndrome

4. A retrospective analysis of false-positive infectious screening results in blood donors

5. Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between HTLV-1/2 infection and COVID-19 severity in a migrant Shipibo-Konibo population in Lima, Peru;PLOS Global Public Health;2024-07-10

2. Global properties of SARS‐CoV‐2 and IAV coinfection model with distributed‐time delays and humoral immunity;Mathematical Methods in the Applied Sciences;2024-04-13

3. Stability of a discrete HTLV-1/SARS-CoV-2 dual infection model;Heliyon;2024-04

4. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature;Frontiers in Molecular Neuroscience;2023-03-17

5. SARS-CoV-2 (COVID-19) infection in patients with HTLV-1 infection in Peru - case series;Journal of Human Virology & Retrovirology;2023-03-13